<?xml version="1.0" encoding="UTF-8" ?>
			<?xml-stylesheet href="/rss/rss2html.xsl" type="text/xsl" media="screen"?>
			<rss version="2.0" xmlns:alacra="http://www.alacra.com" xmlns:bir="http://www.alacra.com/bir" xmlns:ccbn="http://www.alacra.com/ccbn" xmlns:srp="http://www.alacra.com/srp" xmlns:newstex="http://www.alacra.com/newstex" ><channel><title>Array BioPharma Inc. RSS Research Feed - Subscribe Today - AlacraStore.com</title>
<description>Array BioPharma Inc.</description>
<link>http://www.alacrastore.com/company-snapshot/Array_BioPharma_Inc-2105898</link>
<lastBuildDate>Friday, November 21, 2008 12:14:06 AM</lastBuildDate>
<alacra:xlsid>2105898</alacra:xlsid>
<alacra:company>Array BioPharma Inc.</alacra:company>
<language>en</language>
<generator>AlacraStore RSS Builder 1.0</generator>
<ttl>30</ttl>
<item><link>http://www.alacrastore.com/storecontent/newstex/BW-0001-29363161</link><guid isPermaLink="false">newstex/BW-0001-29363161</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> Nov. #, #### (Business Wire) --  Array BioPharma Inc. (NASDAQ: ARRY) today announced that it has filed a shelf registration statement on Form S-# with the Securities and Exchange Commission (SEC). The shelf registration statement, when...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><pubDate>11/7/2008 5:23:53 PM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18025000</newstex:event><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19000000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19001000</newstex:geo><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">Business Wire</newstex:Publication><title>Array BioPharma Inc. Files Shelf Registration Statement</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">BW-0001-29363161</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">ARRAY BIOPHARMA INC</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">ARRY</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T2009583</link><guid isPermaLink="false">ccbn/T2009583</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Good day everyone, and welcome to today's Array BioPharma First Quarter Fiscal #### Financial Results Conference Call. Today's call is being recorded. At this time, for opening remarks, I would like to turn the call over to Tricia Haugeto. Please go ahead. ...

</description><pubDate>11/4/2008 3:07:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Array BioPharma Inc.</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Array BioPharma Inc. Q1 2009 Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">ARRY</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">9:00am ET</ccbn:time><title>Array BioPharma Inc. Q1 2009 Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T2009583</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1986724</link><guid isPermaLink="false">ccbn/T1986724</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>... - William Blair -  AnalystWe'll go ahead and get the next presentation started. For those of you on the webcast this is John Sonnier. I am the biotech  analyst here at William Blair. I am pleased to have Array BioPharma as our next presentation. We have two members of the executive team here today, and Bob, are you giving the entire presentation or are you guys splitting it? ...

</description><pubDate>10/13/2008 11:05:12 AM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Array BioPharma Inc.</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">106.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Array BioPharma Inc. at William Blair &amp; Company Small-Cap Growth Stock Conference Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">ARRY</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">10:40am ET</ccbn:time><title>Array BioPharma Inc. at William Blair &amp; Company Small-Cap Growth Stock Conference Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1986724</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1976028</link><guid isPermaLink="false">ccbn/T1976028</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Good morning, and welcome to the #### UBS Global Life Sciences conference. My name is [Shu Lin] and I'm happy to be your host for this session. Our next presenter is Robert Conway, Chief Executive Officer of Array BioPharma. A breakout session in the Carnegie Hall room will follow immediately after the presentation. Thank you. ...

</description><pubDate>9/30/2008 4:05:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Array BioPharma Inc.</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Array BioPharma Inc. at UBS Global Life Sciences Conference Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">ARRY</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">9:00am ET</ccbn:time><title>Array BioPharma Inc. at UBS Global Life Sciences Conference Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1976028</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1911974</link><guid isPermaLink="false">ccbn/T1911974</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Good day, everyone, and welcome to today's Array BioPharma fourth-quarter and full-year results conference call. Today's call is being recorded. At this time, for opening remarks, I would like to turn the call over to Tricia Haugeto. Please go ahead. ...

</description><pubDate>8/12/2008 12:05:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Array BioPharma Inc.</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Array BioPharma Inc. Q4 2008 Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">ARRY</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">9:00am ET</ccbn:time><title>Array BioPharma Inc. Q4 2008 Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1911974</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/bir/772763</link><guid isPermaLink="false">bir/772763</guid><bir:index_mode xmlns:bir="http://www.alacra.com/bir">norm</bir:index_mode><title>Array Biopharma Inc.</title><bir:company xmlns:bir="http://www.alacra.com/bir">Array Biopharma Inc.</bir:company><bir:cou xmlns:bir="http://www.alacra.com/bir">United States</bir:cou><bir:descr xmlns:bir="http://www.alacra.com/bir">Services: Bio research through genomics.</bir:descr><bir:sic xmlns:bir="http://www.alacra.com/bir">8071</bir:sic><bir:naics xmlns:bir="http://www.alacra.com/bir">621511</bir:naics><bir:class xmlns:bir="http://www.alacra.com/bir">17</bir:class><bir:size xmlns:bir="http://www.alacra.com/bir">D</bir:size><bir:revenue xmlns:bir="http://www.alacra.com/bir">F</bir:revenue><bir:ticker xmlns:bir="http://www.alacra.com/bir">ARRY</bir:ticker><pubDate>5/28/2008 10:08:00 AM</pubDate><bir:docid xmlns:bir="http://www.alacra.com/bir">772763</bir:docid><category>Company Profiles &amp; Financials</category><alacra:ip>Gale Company Profiles</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1840093</link><guid isPermaLink="false">ccbn/T1840093</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Good day everyone and welcome to today's Array BioPharma quarterly conference call. Today's call is being recorded. At this time for opening remarks I would like to turn the call over to Tricia Haugeto, please go ahead. ...

</description><pubDate>5/6/2008 10:06:00 AM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Array BioPharma Inc.</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q3 2008 Array BioPharma Inc. Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">ARRY</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">9:00am ET</ccbn:time><title>Q3 2008 Array BioPharma Inc. Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1840093</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1752230</link><guid isPermaLink="false">ccbn/T1752230</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>Array BioPharma Inc. at BIO CEO &amp; Investor Conference</description><pubDate>2/12/2008 4:32:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Array BioPharma Inc.</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Array BioPharma Inc. at BIO CEO &amp; Investor Conference Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">ARRY</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">11:00am ET</ccbn:time><title>Array BioPharma Inc. at BIO CEO &amp; Investor Conference Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1752230</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1745201</link><guid isPermaLink="false">ccbn/T1745201</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>Q# #### Array BioPharma Inc. Earnings Conference Call</description><pubDate>2/5/2008 10:07:00 AM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Array BioPharma Inc.</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q2 2008 Array BioPharma Inc. Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">ARRY</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">9:00am ET</ccbn:time><title>Q2 2008 Array BioPharma Inc. Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1745201</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1724860</link><guid isPermaLink="false">ccbn/T1724860</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><pubDate>12/31/2007 5:21:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Array BioPharma Inc.</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Array BioPharma Inc. Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">ARRY</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">9:00am ET</ccbn:time><title>Array BioPharma Inc. Conference Call Transcript</title><description>...Good day, everyone, and welcome to today's Array BioPharma conference call. Today's call is being recorded. At this time for opening remarks and introductions, I would like to turn the call over to Trisha Haugeto. Please go ahead. ...

</description><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1724860</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/srp/1973512235</link><guid isPermaLink="false">srp/1973512235</guid><srp:index_mode xmlns:srp="http://www.alacra.com/srp">norm</srp:index_mode><description>...Address:#### Walnut Street, Boulder, Colorado ##### Incorporated:DelawareWeb Site: www.arraybiopharma.comSIC Classification: Medical Laboratories (####) Business Description: Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of orally active drugs to address significant unmet medical needs. The company's proprietary drug development pipeline is primarily focused on the treatment of cancer and inflammatory disease and includes several small molecule drug candidates that are designed to regulate targets in therapeutically important biologic pathways. In addition, leading pharmaceutical and biotechnology companies access the company's drug discovery technologies and expertise through collaborations to design, create, optimize and evaluate drug candidates across a broad range of therapeutic areas. Indices:Russell ####, Russell #### IPO Date: ##-##-####...

</description><srp:company xmlns:srp="http://www.alacra.com/srp">1973512235</srp:company><title>Array BioPharma Inc.</title><srp:cusip xmlns:srp="http://www.alacra.com/srp">04269X105</srp:cusip><srp:ticker xmlns:srp="http://www.alacra.com/srp">ARRY</srp:ticker><pubDate>10/6/2006 12:22:00 PM</pubDate><srp:docid xmlns:srp="http://www.alacra.com/srp">1973512235</srp:docid><category>Credit &amp; Investment Research</category><alacra:ip>SharkRepellent.net</alacra:ip></item></channel></rss>